Research
Mayo Clinic researchers found that GLP-1 receptor agonists, medications widely used for diabetes and weight management, were associated with a lower risk of dialysis or kidney transplantation in adults with bipolar disorder and chronic kidney disease.
Latest stories
Individualized Medicine
November 18, 2025
Research
November 12, 2025
Cardiovascular
November 10, 2025
Research
November 5, 2025
Cardiovascular
November 4, 2025
Research
October 29, 2025
Cancer
October 28, 2025
Sign up to receive email notifications
Explore more topics
Sign up
Mayo Clinic Connect
An online patient support community